Bunker Kevin D.

Chief Scientific OfficerZentalis Pharmaceuticals, Inc. (ZNTL) · full profile →Form 4 · filed Feb 14, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$208K
Net Open-Market Flow
-$208K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2023Sell(S)7K$19.98$130K865K
Feb 13, 2023Sell(S)4K$20.42$78K872K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001725160-23-000031) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.